🔎 Trials Near Me

Home › Lymphoma › Florida › Tampa

Lymphoma clinical trials in Tampa, FL

7 studies for Lymphoma are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

RecruitingPhase 1
  • Moffit Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

RecruitingPhase 3
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06084936

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

RecruitingPhase 1/2
  • Moffitt Cancer Center, Tampa
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT04588922

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

RecruitingPhase 3
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07188558

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

RecruitingPhase 1/2
  • Dren Investigational Site, Tampa
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

RecruitingObservational study
  • Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
All ages · All sexes · Updated May 18, 2026 · NCT01790152

About Lymphoma

Lymphoma is a cancer affecting the immune system. Hodgkins Lymphoma and Non Hodgkins Lymphoma are types of lymphoma. Learn about symptoms and treatments.

More about Lymphoma on MedlinePlus

Lymphoma trials in other cities

Other studies in Tampa

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.